|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07H 19/24 | (2006.01) |
| A61K 31/7064 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2396340 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10704068.5 |
| Date of filing the European patent application | 2010-02-09 | |
| (97) | Date of publication of the European application | 2011-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2013-12-18 |
| (46) | Date of publication of the claims translation | 2014-04-25 |
| (86) | Number | PCT/US2010/023586 |
| Date | 2010-02-09 |
| (87) | Number | WO 2010/093608 |
| Date | 2010-08-19 |
| (30) | Number | Date | Country code |
| 151248 P | 2009-02-10 | US |
| (72) |
BUTLER, Thomas, US
CHO, Aesop, US
KIM, Choung, U., US
XU, Jie, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Karba-nukleozidų analogai, skirti antivirusiniam gydymui |
| CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2019-01-18 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-02-09 |